Alex Spiers

Alex Spiers

Auto-generated profile, based on publicly available information

Alex Spiers

Royal Devon and Exeter NHS Foundation Trust Hospital, Exeter, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CSChen Shen
Chen Shen
RSRachel B Smith
Rachel B Smith
JHJoel Heller
Joel Heller
ASAlexander D V Spiers
Alexander D V Spiers
RTRhiannon Thompson
Rhiannon Thompson
MTMireille B Toledano
Mireille B Toledano
Background: Adolescents are susceptible to mental illness and have experienced substantial disruption owing to the COVID-19 pandemic. The digital environment is increasingly important in the context of a pandemic when in-person social connection is restricted. Objective: This study aims to estimate whether depression and anxiety had worsened compared with the prepandemic period and examine potential associations with sociodemographic characteristics and behavioral factors, particularly digital behaviors. Methods: We analyzed cross-sectional and longitudinal data from a large, representative Greater London adolescent cohort study: the Study of Cognition, Adolescents and Mobile Phones (SCAMP). Participants completed surveys at T1 between November 2016 and July 2018 (N=4978; aged 13 to 15 years) and at T2 between July 2020 and June 2021 (N=1328; aged 16 to 18 years). Depression and anxiety were measured using the Patient Health Questionnaire and Generalized Anxiety Disorder scale, respectively. Information on the duration of total mobile phone use, social network site use, and video gaming was also collected using questionnaires. Multivariable logistic regression was used to assess the cross-sectional and longitudinal associations of sociodemographic characteristics, digital technology use, and sleep duration with clinically significant depression and anxiety. Results: The proportion of adolescents who had clinical depression and anxiety significantly increased at T2 (depression: 140/421, 33.3%; anxiety: 125/425, 29.4%) compared with the proportion of adolescents at T1 (depression: 57/421, 13.5%; anxiety: 58/425, 13.6%; P for 2-proportion z test <.001 for both depression and anxiety). Depression and anxiety levels were similar between the summer holiday, school opening, and school closures. Female participants had higher odds of new incident depression (odds ratio [OR] 2.5, 95% CI 1.5-4.18) and anxiety (OR 2.11, 95% CI 1.23-3.61) at T2. A high level of total mobile phone use at T1 was associated with developing depression at T2 (OR 1.89, 95% CI 1.02-3.49). Social network site use was associated with depression and anxiety cross-sectionally at T1 and T2 but did not appear to be associated with developing depression or anxiety longitudinally. Insufficient sleep at T1 was associated with developing depression at T2 (OR 2.26, 95% CI 1.31-3.91). Conclusions: The mental health of this large sample of adolescents from London deteriorated during the pandemic without noticeable variations relating to public health measures. The deterioration was exacerbated in girls, those with preexisting high total mobile phone use, and those with preexisting disrupted sleep. Our findings suggest the necessity for allocating resources to address these modifiable factors and target high-risk groups.


29 April 2021 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
OTOwen Tomlinson
Owen Tomlinson
ADAnna Duckworth
Anna Duckworth
LMLaura Markham
Laura Markham
RWRebecca Wollerton
Rebecca Wollerton
BKBridget Knight
Bridget Knight
CSChris Scotton
Chris Scotton
Introduction Cardiopulmonary exercise testing (CPET) provides a series of biomarkers, such as peak oxygen uptake, which could assess the development of disease status in interstitial lung disease (ILD). However, despite use in research and clinical settings, the feasibility of CPET in this patient group has yet to be established. Methods Twenty-six patients with ILD (19 male) were recruited to this study. Following screening for contraindications to maximal exercise, participants underwent an incremental CPET to volitional exhaustion. Feasibility of CPET was assessed by the implementation, practicality, acceptability and demand, thus providing clinical-driven and patient-driven information on this testing procedure. Results Of the 26 recruited participants, 24 successfully completed at least one CPET, with 67/78 prospective tests being completed. Contraindications included hypertension, low resting oxygen saturation and recent pulmonary embolism. Of the CPETs undertaken, 63% successfully reached volitional exhaustion, with 31% being terminated early by clinicians due to excessive desaturation. Quantitative and qualitative feedback from participants revealed a positive experience of CPET and desire for it to be included as a future monitoring tool. Conclusion CPET is feasible in patients with ILD. Identification of common clinical contraindications, and understanding of patient perspectives will allow for effective design of future studies utilising CPET as a monitoring procedure.

30 June 2019
Verified
Book Chapter
Open access
PDF file
AMAndrew Middleton
Andrew Middleton
ASAlex Spiers
Alex Spiers
In Andrew Middleton’s chapter he explains what a ‘Twalk’ is, how to design effective Twalks, and why they create useful and rich learning environments. Drawing on his experience organising several Twalks, Andrew set out some emerging issues that should be considered by academics interested in using and developing such novel, blended social media learning spaces, especially if personal learning technologies are used.

12 November 2019 in Thorax
Verified
Conference Paper
Open access
PDF file
RWRl Wollerton
Rl Wollerton
LML Markham
L Markham
OTOw Tomlinson
Ow Tomlinson
BKBa Knight
Ba Knight
ADA Duckworth
A Duckworth
CSCj Scotton
Cj Scotton
Introduction Traditional spirometry measures of forced vital capacity (FVC) and diffusion capacity for carbon monoxide (DLCO) are used in interstitial lung disease (ILD) for prognostic monitoring and evaluating treatment efficacy. Cardiopulmonary exercise testing (CPET) has been proposed as an alternative to spirometry, although it is unknown how the primary outcome of CPET – peak oxygen uptake (VO2peak) – changes relative to both FVC and DLCO. Objectives To identify the direction and magnitude of longitudinal changes in VO2peak, FVC and DLCO in patients with ILD, and identify independence between variables. Methods 21 patients with ILD (17 male, 69.8±7.6 years) performed three CPETs on a cycle ergometer within a mean period of 42±14 weeks. Spirometry was retrospectively obtained from medical records. One-way ANOVA determined significant changes in time. Pearson’s correlation coefficients established relationships between variables. Regression values and correlations were established for each patient’s change in VO2peak, FVC and DLCO. Results The correlation between VO2peak and FVC regressions was r =0.34 (p =0.145) and between VO2peak and DLCO this was r =-0.20 (p =0.432). The majority of patients showed consistent decline in both VO2peak, FVC and DLCO (n =9). However, some patients (n =4) showed an increase in one variable (with decreases in the other two), whilst a further n =4 showed an increase in two variables (decreasing in the third). Conclusions This analysis has shown varied directions and magnitude of change in VO2peak relative to traditional spirometric variables of FVC and DLCO. This confirms the potential utility of CPET as an independent prognostic tool and further investigation is required to assess its clinical utility and associations with alternative clinical markers (e.g. biomarkers, radiology, patient reported outcomes).

12 November 2019 in Thorax
Verified
Conference Paper
Open access
PDF file
OTOw Tomlinson
Ow Tomlinson
LML Markham
L Markham
RWRl Wollerton
Rl Wollerton
BKBa Knight
Ba Knight
ADA Duckworth
A Duckworth
CSCj Scotton
Cj Scotton
Introduction Cardiopulmonary exercise testing (CPET) is shown to be feasible in patients with interstitial lung disease (ILD), highlighting its prospective use as an outcome measure for prognostic monitoring. However, validity and reproducibility, in terms of eliciting maximal exercise and identifying significant changes over time remain unknown. Objectives To identify the validity and reproducibility of CPET in patients with ILD, with particular reference to peak oxygen consumption (VO2peak). Methods Eight males with ILD (68.6±8.2 years) performed two CPETs, 3 months apart on a cycle ergometer. A ‘maximal’ effort was determined if responses met at least one of the criteria established by ATS/ACCP guidelines: plateau in VO2, achieving predicted VO2peak, peak work rate or predicted peak heart rate, and a respiratory exchange ratio >1.15. Pearson’s correlation and paired samples t-test established the relationship, and difference, between VO2peak values from each CPET. Reproducibility of VO2peak was characterised by means of absolute typical error (TE) and typical error as a percentage of the coefficient of variation (TECV%). Results Mean time between CPETs was 14±1 weeks. Reasons for termination included exhaustion (n =11), desaturation (n =4) and poor ECG signal (n =1). All CPETs satisfied at least one of the required ATS/ACCP criteria, with 10/16 satisfying two criteria. The most common criteria was RER >1.15, being satisfied in 15/16 CPETs. Mean VO2peak at the first CPET was 1.38±0.39 L.min-1, and 1.25±0.25 L.min-1 at the second. The mean change of -0.13±0.14 L.min-1 was not statistically significant (p =0.14). VO2peak data from both CPETs were highly correlated (r =0.85, p =0.008). TE of VO2peak over this period was 0.16 L.min-1, with TECV% being 11.8%. Conclusions This analysis has shown that CPET is valid and reliable in ILD. Maximal efforts can be identified through use of ATS/ACCP criteria and repeatability over 3 months is ∼12%. Any change in VO2peak beyond this value implies a significant change in function, which can in turn affect clinical decisions regarding prognosis and treatment.